APA (7th ed.) Citation

Farzin, A. O., Hossein-Khannazer, N., Arjmand, B., Asri, N., Razzaghi, Z., Rezaei-Tavirani, M., . . . Mohaghegh-Shalmani, H. (2025). Introducing ICAM1 as a possible drug target in treatment of eosinophilic esophagitis. Gastroenterology & Hepatology from Bed to Bench, 18, 12. https://doi.org/10.22037/ghfbb.v18iSpecialIssue.3235

Chicago Style (17th ed.) Citation

Farzin, Alireza Omidi, Nikoo Hossein-Khannazer, Babak Arjmand, Nastaran Asri, Zahra Razzaghi, Mostafa Rezaei-Tavirani, Mohammad Javad Ehsani Ardakani, and Hamid Mohaghegh-Shalmani. "Introducing ICAM1 as a Possible Drug Target in Treatment of Eosinophilic Esophagitis." Gastroenterology & Hepatology from Bed to Bench 18 (2025): 12. https://doi.org/10.22037/ghfbb.v18iSpecialIssue.3235.

MLA (9th ed.) Citation

Farzin, Alireza Omidi, et al. "Introducing ICAM1 as a Possible Drug Target in Treatment of Eosinophilic Esophagitis." Gastroenterology & Hepatology from Bed to Bench, vol. 18, 2025, p. 12, https://doi.org/10.22037/ghfbb.v18iSpecialIssue.3235.